16 pending office actions • 13 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18649917 | ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE | Sichuan Real&Best Biotech Co., Ltd. | MOEHLMAN, ANDREW TERRY | 1655 | Non-Final OA | Apr 29, 2024 |
| 18684902 | ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | CHAO, ALLEN | 1622 | Non-Final OA | Feb 20, 2024 |
| 18542629 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Dec 16, 2023 |
| 18505975 | INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | NucMito Pharmaceuticals Co., Ltd. | FOWLER, ALAN JEROME | 1691 | Non-Final OA | Nov 09, 2023 |
| 18558522 | PYRIMIDINYLAMINOBENZENES FOR LUNG CANCER TREATMENT | Suzhou Puhe BioPharma Co., Ltd. | HEES, OLIVER DRAGON | 1628 | Non-Final OA | Nov 01, 2023 |
| 18550967 | FUSION PROTEINS COMPRISING GG REPEAT SEQUENCES | Numaferm GmbH | MCKNIGHT, CIARA A | 1656 | Non-Final OA | Sep 17, 2023 |
| 18547018 | CRYPTOPHYCIN COMPOUNDS AND CONJUGATES THEREOF | Universitat Bielefeld | BRAUN, MADELINE E | 1624 | Non-Final OA | Aug 18, 2023 |
| 18256636 | PDE4 DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | MCDOWELL, BRIAN E | 1624 | Non-Final OA | Jun 09, 2023 |
| 18256237 | RXR-ALPHA BINDERS AND RXR-ALPHA/PLK1 MODULATORS | NucMito Pharmaceuticals Co., Ltd. | STEIN, LEAH ELIZABETH | 1641 | Non-Final OA | Jun 07, 2023 |
| 18255855 | HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | Eubulus Biotherapeutics Inc. | SHOWALTER, ALEXANDER KEITH | 1629 | Non-Final OA | Jun 02, 2023 |
| 18245125 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | WHITE, DAWANNA SHAR-DAY | 1627 | Final Rejection | Mar 13, 2023 |
| 18174565 | COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY | Crage Medical Co., Limited | BELYAVSKYI, MICHAIL A | 1644 | Non-Final OA | Feb 24, 2023 |
| 17999843 | BIARYLSULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING FIBROTIC LUNG DISEASE | NovoMedix, LLC | WELLS, LAUREN QUINLAN | 1622 | Final Rejection | Nov 23, 2022 |
| 17634963 | GENETICALLY ENGINEERED CELLS AND USES THEREOF | Cure Genetics Co., Limited | DIBRINO, MARIANNE | 1641 | Non-Final OA | Nov 09, 2022 |
| 17806689 | ASCORBIC ACID AND QUINONE COMPOUND FOR CANCER TREATMENT | Ic-Medtech Corp. | SIMMONS, CHRIS E | 1622 | Final Rejection | Jun 13, 2022 |
| 17623481 | CELL FOR RESISTING TRANSPLANT REACTION AND METHOD | Carsgen Life Sciences Co., Ltd. | TRAN, KHOA NHAT | 1632 | Non-Final OA | Dec 28, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial